JournalsHub
.online
Find My Journal
LA

Leila Arabi

Mashhad University of Medical Sciences IR

ORCID iD 0000-0003-1623-3346
58
Publications
1,583
Citations
19
H-Index
26
i10-Index
5.61
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
Luca Quagliata, Matthias S. Matter, Salvatore Piscuoglio, Leila Arabi, Christian Ruiz +12 more
Hepatology 2013
442
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
Leila Arabi, Ali Badiee, Fatemeh Mosaffa, Mahmoud Reza Jaafari
Journal of Controlled Release 2015
182
Doxorubicin-loaded composite nanogels for cancer treatment
Marzieh Mohammadi, Leila Arabi, Mona Alibolandi
Journal of Controlled Release 2020
127
Redox-sensitive nanoscale drug delivery systems for cancer treatment
Elaheh Mirhadi, Mohammad Mashreghi, Mahdi Faal Maleki, Seyedeh Hoda Alavizadeh, Leila Arabi +2 more
International Journal of Pharmaceutics 2020
117
Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
Sedigheh Shahvali, Niloufar Rahiman, Mahmoud Reza Jaafari, Leila Arabi
Drug Delivery and Translational Research 2023
86

Publications

58 total

pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: an emerging modality for treating breast cancer PDF

Leila Farhoudi, Seyedeh Maryam Hosseinikhah, Amin Kazemi‐Beydokhti, Leila Arabi, Seyedeh Hoda Alavizadeh et al. - Cancer Nanotechnology, 2024
Cited by 26 OpenAlex

Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy

Sedigheh Shahvali, Niloufar Rahiman, Mahmoud Reza Jaafari, Leila Arabi - Drug Delivery and Translational Research, 2023
Cited by 86 OpenAlex

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy PDF

Anis Askarizadeh, Mohammad Mashreghi, Elaheh Mirhadi, Farshad Mirzavi, Vahid Heravi Shargh et al. - Cancer Nanotechnology, 2023
Cited by 50 OpenAlex

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy PDF

Elaheh Mirhadi, Mohammad Mashreghi, Anis Askarizadeh, Amin Mehrabian, Seyedeh Hoda Alavizadeh et al. - Scientific Reports, 2022
Cited by 47 OpenAlex

Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis

Niloufar Rahiman, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, Leila Arabi, Ali Badiee et al. - Journal of Controlled Release, 2022
Cited by 29 OpenAlex

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers PDF

Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, Ali Badiee, Leila Arabi et al. - Technology in Cancer Research & Treatment, 2022
Cited by 27 OpenAlex

Doxorubicin-loaded composite nanogels for cancer treatment

Marzieh Mohammadi, Leila Arabi, Mona Alibolandi - Journal of Controlled Release, 2020
Cited by 127 OpenAlex

Redox-sensitive nanoscale drug delivery systems for cancer treatment

Elaheh Mirhadi, Mohammad Mashreghi, Mahdi Faal Maleki, Seyedeh Hoda Alavizadeh, Leila Arabi et al. - International Journal of Pharmaceutics, 2020
Cited by 117 OpenAlex

Immunoengineering in glioblastoma imaging and therapy

Saeid Zanganeh, Petrina Georgala, Claudia Corbo, Leila Arabi, Jim Q. Ho et al. - Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 2019
Cited by 27 OpenAlex

5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells PDF

Seyedeh Alia Moosavian, Khalil Abnous, Javad Akhtari, Leila Arabi, Ali Gholamzade Dewin et al. - Artificial Cells Nanomedicine and Biotechnology, 2017
Cited by 54 OpenAlex

Research Topics

Nanoparticle-Based Drug Delivery (21) RNA Interference and Gene Delivery (13) Nanoplatforms for cancer theranostics (11) Immunotherapy and Immune Responses (8) Cancer Cells and Metastasis (5)

Frequent Co-Authors

MA
Mahmoud Reza Jaafari
10 joint publications
AL
Ali Badiee
7 joint publications
SE
Seyedeh Hoda Alavizadeh
6 joint publications
MO
Mohammad Mashreghi
4 joint publications
EL
Elaheh Mirhadi
3 joint publications
SE
Seyedeh Alia Moosavian
3 joint publications

Affiliations

Mashhad University of Medical Sciences
IR 2026 - 2014
University of Basel
CH 2020 - 2020
University Hospital of Basel
CH 2016 - 2013
Biotechnology Research Center
IR 2017 - 2015
Dentsply Sirona (United States)
US 2017 - 2017

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now